Oliveira M, da Silva N, Antunes E, Sousa L, Bico P, Conceição J M, Roquette J, Antunes A M
Serviço de Cardiologia, Hospital de Santa Marta, Lisboa.
Rev Port Cardiol. 1998 Dec;17(12):1013-20.
In patients (pts) with implantable cardioverter-defibrillators (ICD), antitachycardia pacing (ATP) schemes may be used followed by a limited number of endocavitary shocks in the same episode of ventricular tachycardia (VT) with the potential risk of therapeutic exhaustion.
To assess the incidence of episodes of therapeutic exhaustion in a population of ICD carriers with ATP programmes and to attempt to determine their correlation with clinical variables.
Study of the episodes of VT treated by ICD in 8 patients (6 male; 2 female) with an average age of 56 +/- 17 years with a follow-up > 6 months. The underlying pathology was: ischemic heart disease-5 patients; arrhythmogenic dysplasia of the right ventricle-1 patient; hypertrophic cardiomyopathy-1 patient; and operated pulmonary valve stenosis-1 patient. The authors considered therapeutic exhaustion to be the occurrence of episodes in which VT persisted after the application of ATP and the maximum number of shocks. The patients with episodes of therapeutic exhaustion (group A-3 patients) were compared with the remaining patients (group B-5 patients) with regard to the following parameters: age; ejection fraction; previous myocardial infarction (pMI; cardiac frequency during VT (cfVT); number of episodes of non-maintained VT (NMVT) without therapeutic intervention; > 20% reduction of the VT cycle after ATP (VTATP); intensity of programmable shocks (Icho); and medication with anti-arrhythmia drugs (AA).
In a total of 262 VT records (duration > 2.5 sec. after detection) with treatment by ICD during an average follow-up of 11 months, 6 episodes (2.3%) of therapeutic exhaustion were detected in 3 patients. Four of the episodes occurred in the same patient in a period of 4 hours, hospitalisation being necessary following syncope. In the other two cases, there were complaints of dizziness which subsided spontaneously a short time after the application of the last shock by the ICD. [table: see text]
Therapeutic exhaustion occurred in about 2% of the VT treated with this population. The possibility of a high number of non maintained VT episodes being associated to a greater possibility of therapeutic exhaustion may have implications on ICD programming.
在植入式心脏复律除颤器(ICD)患者中,抗心动过速起搏(ATP)方案可在同一室性心动过速(VT)发作时使用,随后进行有限次数的心腔内电击,存在治疗耗竭的潜在风险。
评估有ATP程序的ICD携带者群体中治疗耗竭发作的发生率,并试图确定其与临床变量的相关性。
对8例平均年龄56±17岁、随访时间>6个月的患者(6例男性;2例女性)进行ICD治疗的VT发作研究。基础病理情况为:缺血性心脏病5例;右心室致心律失常性发育异常1例;肥厚型心肌病1例;手术治疗的肺动脉瓣狭窄1例。作者将治疗耗竭定义为在应用ATP和最大电击次数后VT仍持续发作的情况。将发生治疗耗竭发作的患者(A组-3例)与其余患者(B组-5例)在以下参数方面进行比较:年龄;射血分数;既往心肌梗死(pMI);VT期间的心率(cfVT);无治疗干预的非持续性VT(NMVT)发作次数;ATP后VT周期缩短>20%(VTATP);可编程电击强度(Icho);以及抗心律失常药物(AA)用药情况。
在平均11个月的随访期间,共有262次VT记录(检测后持续时间>2.5秒)接受ICD治疗,3例患者中检测到6次(2.3%)治疗耗竭发作。其中4次发作发生在同一患者4小时内,晕厥后需要住院治疗。另外2例患者,在ICD最后一次电击后短时间内出现头晕症状,随后自行缓解。[表格:见原文]
该群体中约2%接受治疗的VT发生了治疗耗竭。大量非持续性VT发作可能与更高的治疗耗竭可能性相关,这可能对ICD编程有影响。